Abbott & Andrx Settle Biaxin Litigation

Posted on July 18, 2007 by R. David Donoghue
Abbott Laboratories and Andrx Pharmaceuticals have settled their Northern District patent litigation over Andrx's efforts to sell a generic version of Abbott's extended release antibiotic Biaxin XL, Case No.05 C 1490 (discussed at length in the Blog's archives).  According to IP Law360 (subscription required), the settlement includes an agreement that Andrx will not market a generic version of Biaxin XL for, presumably, the remainder of Abbott's patent term.
Tags: , , , , ,
Trackbacks (0) Links to blogs that reference this article Trackback URL
http://www.chicagoiplitigation.com/admin/trackback/35002
Comments (0) Read through and enter the discussion with the form at the end
Post A Comment / Question Use this form to add a comment to this entry.







Remember personal info?
Send To A Friend Use this form to send this entry to a friend via email.